letrozole and Uterine Neoplasms
letrozole has been researched along with Uterine Neoplasms in 20 studies
Uterine Neoplasms: Tumors or cancer of the UTERUS.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
" Here we report a case of lobular breast cancer metastasizing to a leiomyoma in a patient using letrozole." | 7.77 | Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment. ( Aydinli, K; Basgul, AY; Calay, Z; Dünder, I; Güdücü, N; Işçi, H, 2011) |
"Letrozole was found to be well tolerated." | 6.79 | Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. ( Butrynski, JE; Demetri, GD; Feng, Y; George, S; Harmon, D; Krasner, C; Manola, J; Morgan, JA; Nucci, MR; Penson, RT; Quek, R; Ramaiya, N; Wagner, AJ, 2014) |
"Uterine leiomyomas are the most common benign tumours of the female genital tract, often necessitating hysterectomy." | 6.73 | Treatment of symptomatic uterine leiomyoma with letrozole. ( Celik, H; Gurates, B; Kilic, G; Kumru, S; Parmaksiz, C; Simsek, M, 2008) |
"Slow disease progression after a poor response to adriamycin and hormone receptor positivity led to the start of letrozole." | 5.91 | Long-term effect of letrozole on metastatic uterine smooth muscle tumors of uncertain malignant potential: A case report. ( Hayashi, T; Kato, S; Kido, H; Naito, T; Praben, P; Takagi, T; Terao, Y, 2023) |
"Condensation letrozole in combination with cabergoline in the management of uterine fibroids." | 5.24 | Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial. ( Gharabaghi, PM; Mobasseri, M; Ouladsahebmadarek, E; Rahmani, V; Sayyah-Melli, M, 2017) |
" Here we report a case of lobular breast cancer metastasizing to a leiomyoma in a patient using letrozole." | 3.77 | Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment. ( Aydinli, K; Basgul, AY; Calay, Z; Dünder, I; Güdücü, N; Işçi, H, 2011) |
"Letrozole was found to be well tolerated." | 2.79 | Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. ( Butrynski, JE; Demetri, GD; Feng, Y; George, S; Harmon, D; Krasner, C; Manola, J; Morgan, JA; Nucci, MR; Penson, RT; Quek, R; Ramaiya, N; Wagner, AJ, 2014) |
"The quality of the myometrial scar, defined by ultrasound evaluation, was similar in the two study groups both at one-week (p=0." | 2.79 | Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study. ( Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL, 2014) |
"Uterine leiomyomas are the most common benign tumours of the female genital tract, often necessitating hysterectomy." | 2.73 | Treatment of symptomatic uterine leiomyoma with letrozole. ( Celik, H; Gurates, B; Kilic, G; Kumru, S; Parmaksiz, C; Simsek, M, 2008) |
"Uterine fibroids, also called uterine leiomyomas or myomas, are the most common benign tumours in women of reproductive age." | 2.49 | Aromatase inhibitors for uterine fibroids. ( Lu, D; Navaratnam, K; Shi, G; Song, H, 2013) |
"Slow disease progression after a poor response to adriamycin and hormone receptor positivity led to the start of letrozole." | 1.91 | Long-term effect of letrozole on metastatic uterine smooth muscle tumors of uncertain malignant potential: A case report. ( Hayashi, T; Kato, S; Kido, H; Naito, T; Praben, P; Takagi, T; Terao, Y, 2023) |
"Intra- and postoperative complications, postoperative pain, and patient satisfaction were similar in the four study groups." | 1.42 | Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. ( Bizzarri, N; Ferrero, S; Ghirardi, V; Remorgida, V; Venturini, PL, 2015) |
Research
Studies (20)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (35.00) | 29.6817 |
2010's | 12 (60.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Praben, P | 1 |
Kido, H | 1 |
Terao, Y | 1 |
Takagi, T | 1 |
Hayashi, T | 1 |
Naito, T | 1 |
Kato, S | 1 |
Martin-Romano, P | 1 |
Jurado, M | 1 |
Idoate, MA | 1 |
Arbea, L | 1 |
Hernandez-Lizoain, JL | 1 |
Cano, D | 1 |
Paramo, JA | 1 |
Martin-Algarra, S | 1 |
Duhan, N | 1 |
Madaan, S | 1 |
Sen, J | 1 |
Song, H | 1 |
Lu, D | 1 |
Navaratnam, K | 1 |
Shi, G | 1 |
George, S | 2 |
Feng, Y | 1 |
Manola, J | 1 |
Nucci, MR | 2 |
Butrynski, JE | 1 |
Morgan, JA | 1 |
Ramaiya, N | 1 |
Quek, R | 1 |
Penson, RT | 1 |
Wagner, AJ | 1 |
Harmon, D | 1 |
Demetri, GD | 1 |
Krasner, C | 1 |
Serrano, C | 1 |
Tirumani, SH | 1 |
Raut, CP | 1 |
Leone Roberti Maggiore, U | 1 |
Scala, C | 1 |
Venturini, PL | 3 |
Ferrero, S | 3 |
Bizzarri, N | 1 |
Ghirardi, V | 1 |
Remorgida, V | 2 |
Sayyah-Melli, M | 1 |
Mobasseri, M | 1 |
Gharabaghi, PM | 1 |
Ouladsahebmadarek, E | 1 |
Rahmani, V | 1 |
Gurates, B | 1 |
Parmaksiz, C | 1 |
Kilic, G | 1 |
Celik, H | 1 |
Kumru, S | 1 |
Simsek, M | 1 |
Parsanezhad, ME | 1 |
Azmoon, M | 1 |
Alborzi, S | 1 |
Rajaeefard, A | 1 |
Zarei, A | 1 |
Kazerooni, T | 1 |
Frank, V | 1 |
Schmidt, EH | 1 |
Işçi, H | 1 |
Güdücü, N | 1 |
Basgul, AY | 1 |
Aydinli, K | 1 |
Calay, Z | 1 |
Dünder, I | 1 |
Komeda, S | 1 |
Furukawa, N | 1 |
Kasai, T | 1 |
Washida, A | 1 |
Kobayashi, H | 1 |
Pink, D | 1 |
Lindner, T | 1 |
Mrozek, A | 1 |
Kretzschmar, A | 1 |
Thuss-Patience, PC | 1 |
Dörken, B | 1 |
Reichardt, P | 1 |
Bréchot, JM | 1 |
Kamboucher, M | 1 |
Brauner, M | 1 |
Destable, MD | 1 |
Duperron, F | 1 |
Morère, JF | 1 |
Biri, A | 1 |
Korucuoglu, U | 1 |
Zumrutbas, N | 1 |
Tiras, B | 1 |
Guner, H | 1 |
Thiery-Vuillemin, A | 1 |
Chaigneau, L | 1 |
Meaux-Ruault, N | 1 |
Villanueva, C | 1 |
N'guyen, T | 1 |
Maurina, T | 1 |
Stein, U | 1 |
Lorgis, V | 1 |
Demarchi, M | 1 |
Pivot, X | 1 |
Bershteĭn, LM | 1 |
Maksimov, SIa | 1 |
Gershfel'd, ED | 1 |
Gamaiunova, VB | 1 |
Tsyrlina, EV | 1 |
Meshkova, IE | 1 |
Kovalenko, IG | 1 |
Larionov, AA | 1 |
Kovalevskiĭ, AIu | 1 |
Vasil'ev, DA | 1 |
Mor, G | 1 |
Eliza, M | 1 |
Song, J | 1 |
Wiita, B | 1 |
Chen, S | 1 |
Naftolin, F | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Influence of the Aromatase Inhibitor Anastrozole and GnRH Analog Goserelin Acetate as Preoperative Treatment of Vaginal Surgical Treatment of Uterine Leiomyoma: Analysis of Intra and Immediate/Late Postoperative Patterns[NCT01280045] | 5 participants (Actual) | Interventional | 2011-01-31 | Terminated (stopped due to No grant was received then we stopped the recruitment) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
1 review available for letrozole and Uterine Neoplasms
Article | Year |
---|---|
Aromatase inhibitors for uterine fibroids.
Topics: Antineoplastic Agents; Aromatase Inhibitors; Female; Hot Flashes; Humans; Leiomyoma; Letrozole; Nitr | 2013 |
Aromatase inhibitors for uterine fibroids.
Topics: Antineoplastic Agents; Aromatase Inhibitors; Female; Hot Flashes; Humans; Leiomyoma; Letrozole; Nitr | 2013 |
Trials
5 trials available for letrozole and Uterine Neoplasms
Article | Year |
---|---|
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
Topics: Adult; Aged; Antineoplastic Agents; Aromatase Inhibitors; Disease-Free Survival; Drug Administration | 2014 |
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
Topics: Adult; Aged; Antineoplastic Agents; Aromatase Inhibitors; Disease-Free Survival; Drug Administration | 2014 |
Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
Topics: Adult; Antineoplastic Agents; Blood Loss, Surgical; Chemotherapy, Adjuvant; Cicatrix; Contraceptives | 2014 |
Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
Topics: Adult; Antineoplastic Agents; Blood Loss, Surgical; Chemotherapy, Adjuvant; Cicatrix; Contraceptives | 2014 |
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Cabergoline; Drug Therapy, Combination; Ergoline | 2017 |
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Cabergoline; Drug Therapy, Combination; Ergoline | 2017 |
Treatment of symptomatic uterine leiomyoma with letrozole.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Bone and Bones; Bone Density; Female; Follicle S | 2008 |
Treatment of symptomatic uterine leiomyoma with letrozole.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Bone and Bones; Bone Density; Female; Follicle S | 2008 |
A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Estradiol; Female; Follicle Stimulatin | 2010 |
A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Estradiol; Female; Follicle Stimulatin | 2010 |
Other Studies
14 other studies available for letrozole and Uterine Neoplasms
Article | Year |
---|---|
Long-term effect of letrozole on metastatic uterine smooth muscle tumors of uncertain malignant potential: A case report.
Topics: Disease Progression; Doxorubicin; Female; Humans; Letrozole; Lung Neoplasms; Middle Aged; Smooth Mus | 2023 |
Long-term effect of letrozole on metastatic uterine smooth muscle tumors of uncertain malignant potential: A case report.
Topics: Disease Progression; Doxorubicin; Female; Humans; Letrozole; Lung Neoplasms; Middle Aged; Smooth Mus | 2023 |
Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
Topics: Aromatase Inhibitors; Blood Coagulation Disorders; Bone Neoplasms; Carcinosarcoma; Female; Humans; L | 2017 |
Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report.
Topics: Aromatase Inhibitors; Blood Coagulation Disorders; Bone Neoplasms; Carcinosarcoma; Female; Humans; L | 2017 |
Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Topics: Adult; Aromatase Inhibitors; Female; Humans; Leiomyoma; Letrozole; Middle Aged; Nitriles; Premenopau | 2013 |
Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Topics: Adult; Aromatase Inhibitors; Female; Humans; Leiomyoma; Letrozole; Middle Aged; Nitriles; Premenopau | 2013 |
Hormone dependency in metastatic low-grade leiomyosarcoma following uterine smooth muscle tumour of uncertain malignant potential.
Topics: Adult; Aromatase Inhibitors; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysterectomy; | 2014 |
Hormone dependency in metastatic low-grade leiomyosarcoma following uterine smooth muscle tumour of uncertain malignant potential.
Topics: Adult; Aromatase Inhibitors; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hysterectomy; | 2014 |
Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Attitude of Health Personnel; Contrace | 2015 |
Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Attitude of Health Personnel; Contrace | 2015 |
Letrozole monotherapy in the treatment of uterine myomas.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 2010 |
Letrozole monotherapy in the treatment of uterine myomas.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 2010 |
Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment.
Topics: Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Leiomyoma; Letrozole; Mi | 2011 |
Lobular carcinoma of the breast metastasizing to leiomyoma in a patient under letrozole treatment.
Topics: Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Leiomyoma; Letrozole; Mi | 2011 |
Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy.
Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lobula | 2013 |
Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy.
Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lobula | 2013 |
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Endometrial Stromal Tumors; Estrogen Replacement Thera | 2006 |
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Endometrial Stromal Tumors; Estrogen Replacement Thera | 2006 |
[Pulmonary metastases from endometrial stromal sarcoma may benefit from hormone therapy].
Topics: Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letrozole; Lung Neoplasms; Middle Aged; | 2007 |
[Pulmonary metastases from endometrial stromal sarcoma may benefit from hormone therapy].
Topics: Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letrozole; Lung Neoplasms; Middle Aged; | 2007 |
Intravenous leiomyomatosis treated with aromatase inhibitor therapy.
Topics: Adult; Angiography; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Nitriles; Treat | 2008 |
Intravenous leiomyomatosis treated with aromatase inhibitor therapy.
Topics: Adult; Angiography; Aromatase Inhibitors; Female; Humans; Leiomyomatosis; Letrozole; Nitriles; Treat | 2008 |
Anticancer therapy in patients with porphyrias: evidence today.
Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Docetaxel; Epoetin Alfa; | 2008 |
Anticancer therapy in patients with porphyrias: evidence today.
Topics: Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Docetaxel; Epoetin Alfa; | 2008 |
[Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects].
Topics: Antineoplastic Agents; Aromatase Inhibitors; Blood Glucose; Chemotherapy, Adjuvant; Enzyme Inhibitor | 2001 |
[Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects].
Topics: Antineoplastic Agents; Aromatase Inhibitors; Blood Glucose; Chemotherapy, Adjuvant; Enzyme Inhibitor | 2001 |
17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture.
Topics: Aromatase; Aromatase Inhibitors; Binding, Competitive; Cell Line; Choriocarcinoma; Dose-Response Rel | 2001 |
17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture.
Topics: Aromatase; Aromatase Inhibitors; Binding, Competitive; Cell Line; Choriocarcinoma; Dose-Response Rel | 2001 |